AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (November 14, 2007). doi:10.1152/ajprenal.00386.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/1/F229    most recent
00386.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shi, H.
Right arrow Articles by Goligorsky, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shi, H.
Right arrow Articles by Goligorsky, M. S.
Submitted on August 14, 2007
Accepted on November 12, 2007

Glial cell line-derived neurotrophic growth factor increases motility and survival of cultured mesenchymal stem cells and ameliorates acute kidney injury

Haikun Shi1, Daniel Patschan1, Gunnar PH Dietz2, Mathias Bahr3, Matthew Plotkin1, and Michael S. Goligorsky4*

1 Medicine, NYMC, Valhalla, New York, United States
2 Neurology, Neurologische Universitaetsklinik, Goettingen, Germany
3 Neurology, Medical University, Goettingen, Germany
4 Nephrology Division and Renal Research Institute, New York Medical College, Valhalla, New York, United States

* To whom correspondence should be addressed. E-mail: michael_goligorsky{at}nymc.edu.

Glial cell line-derived neurotrophic growth factor (GDNF), a member of the transforming growth factor family, is necessary for renal organogenesis and exhibits changes of expression in models of renal disease. Having demonstrated the participation of nestin-expressing cells in renoprotection, we hypothesized that growth factors and transcription factors similar to those operating in the nervous system should be also operant in the kidney. Using cultured kidney-derived mesenchymal stem cells (MSC) abundantly expressing nestin, we confirmed expression of GDNF by these cells and demonstrated GDNF-induced expression of GDNF. The cellular expression of nestin paralleled that of GDNF expression. Immunohistochemical and Western blot analyses of kidneys obtained from post-ischemic mice showed that expression of GDNF was much enhanced in the renal cortex, a pattern similar to the previously reported expression of nestin. GDNF-treated mice were protected against acute ischemia. To address potential mechanisms of the observed renoprotection, in vitro studies showed that GDNF accelerated MSC migration in a wound healing assay. Hypoxia did not accelerate the motility of MSC and reduced the expression of GDNF in MSC by approximately 2-fold. GDNF was cytoprotective against oxidative stress-induced apoptotic death of MSC. Collectively, these data establish a) an autoregulatory circuit of GDNF-induced GDNF expression in renal MSC; b) induction of GDNF expression in post-ischemic kidneys; c) the ability of exogenous GDNF to ameliorate ischemic renal injury; and d) a possible contribution of GDNF-induced motility and improved survival of MSC to renoprotection.




This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
H Qi, D-Q Li, F Bian, E Y Chuang, D B Jones, and S C Pflugfelder
Expression of glial cell-derived neurotrophic factor and its receptor in the stem-cell-containing human limbal epithelium
Br. J. Ophthalmol., September 1, 2008; 92(9): 1269 - 1274.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. S. Razzaque
Can patient-specific stem cell therapy enhance renal repair?
Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1826 - 1830.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.